Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma Nasha ZhangYan ZhengMing Yang Original Article 21 March 2019 Pages: 1089 - 1099
The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors Yuki KogaMasaaki IwatsukiHideo Baba Original Article 11 March 2019 Pages: 1100 - 1108
DNA methylation genome-wide analysis in remnant and primary gastric cancers Kiichi SugimotoTomoaki ItoMalcolm V. Brock Original Article 12 March 2019 Pages: 1109 - 1120
A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer Xiaohui ZhaoDongfang DaiDeqiang Wang Original Article 15 April 2019 Pages: 1121 - 1129
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications Steffen M. HecklViva WiesenerChristoph Röcken Original Article Open access 15 April 2019 Pages: 1130 - 1142
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer Koki NakanishiMitsuro KandaYasuhiro Kodera Original Article 04 May 2019 Pages: 1143 - 1152
Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer Minkyu JungKyu Hyun ParkSun Young Rha Original Article 16 May 2019 Pages: 1153 - 1163
Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact Joo Yeon KimWoo Gyeong KimDo Youn Park Original Article 31 May 2019 Pages: 1164 - 1175
Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study Hiroki OsumiHiroshi KawachiJunko Fujisaki Original Article 06 May 2019 Pages: 1176 - 1182
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features Yakun WangLi SunXiaotian Zhang Original Article Open access 15 April 2019 Pages: 1183 - 1192
KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study Lindsay C. HewittYuichi SaitoHeike I. Grabsch Original Article Open access 20 May 2019 Pages: 1193 - 1203
Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study Lindsay C. HewittYuichi SaitoHeike I. Grabsch Correction 06 June 2019 Pages: 1204 - 1205
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer Tae-Yong KimHye Sook HanYung-Jue Bang Original Article 03 April 2019 Pages: 1206 - 1214
Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset Koki NakanishiMitsuro KandaYasuhiro Kodera Original Article 06 April 2019 Pages: 1215 - 1225
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis Beate RauAndreas BrandlMatthias Biebl Original Article 07 May 2019 Pages: 1226 - 1237
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer Daisuke TakahariKeisho ChinKensei Yamaguchi Original Article 17 May 2019 Pages: 1238 - 1246
Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer? Masahiro TsujiuraNaoki HikiToshiharu Yamaguchi Original Article 19 March 2019 Pages: 1247 - 1255
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy Ryo TakahashiManabu OhashiNaoki Hiki Original Article 15 March 2019 Pages: 1256 - 1262
Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study I. MokademW. P. M. DijksterhuisR. H. A. Verhoeven Original Article Open access 04 April 2019 Pages: 1263 - 1273
Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy? Masato HayashiTakaki YoshikawaToshirou Nishida Original Article 03 April 2019 Pages: 1274 - 1284
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study Leonardo SolainiSilvia MinistriniPaolo Morgagni Original Article 07 May 2019 Pages: 1285 - 1293
Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection Yasuhiro MitsuiAyaka MiyoshiTetsuji Takayama Case Report 16 September 2019 Pages: 1294 - 1300
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis Hiroshi KatayamaAkira TsuburayaMitsuru Sasako Short Communication 01 July 2019 Pages: 1301 - 1307
Always randomize as late as possible Erik van WerkhovenParvin TajikPatrick M. Bossuyt Letter to the Editor 08 April 2019 Pages: 1308 - 1309
Report about the present condition of Billroth’s stomach specimens Hiroshi SatoHirokazu Noshiro Letter to the Editor 09 July 2019 Pages: 1310 - 1311
Comment on: “Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features. Gastric Cancer, 2019: 1–10” by Wang et al. Chaoran Yu Letter to the Editor 23 August 2019 Pages: 1312 - 1312
